Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary

Prev Chapter
Prev Page
Next Page
Next Chapter

Prev Chapter
Prev Page
Next Page
Next Chapter

PAPERBACK
$63.25

Download

Table of Contents
Front Matter R1-R8
Workshop Summary 1-30
References 31-34
Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults 35-36
Appendix B Workshop Participants 37-38
Appendix C Workshop Speaker and Staff Biographies 39-44
Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD. 45-60
Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S. 61-72
Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema 73-83
Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus 84-104
Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S. 105-117
Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D., 118-153
Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H. 154-188
Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D. 189-207
Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D. 208-219
Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S. 220-231
Appendix N Preliminary Results from CDC 232-240
Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H. 241-262
Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D. 263-284
Appendix Q CISNET—Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D. 285-300

REFERENCES

Ness RM, Holmes A, Klein R, Greene J, Dittus R. 1998. Outcome states of colorectal cancer: Identification and description using patient focus groups. Am J Gastroenterol 93(9):1491–1497 .

Pignone M, Saha S, Hoerger T, Mandelblatt J. 2002. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 137(2):96–104.

Table of Contents

Front Matter R1-R8

Workshop Summary 1-30

References 31-34

Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults 35-36

Appendix B Workshop Participants 37-38

Appendix C Workshop Speaker and Staff Biographies 39-44

Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD. 45-60

Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S. 61-72

Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema 73-83

Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus 84-104

Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S. 105-117

Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D., 118-153

Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H. 154-188

Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D. 189-207

Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D. 208-219

Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S. 220-231

Appendix N Preliminary Results from CDC 232-240

Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H. 241-262

Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D. 263-284

Appendix Q CISNET—Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D. 285-300

REFERENCES